Principales conclusions et analyse des parts de marché des traitements contre le mélanome d'ici 2025-2031
Melanoma Therapeutics Market Report Analysis
Melanoma Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- AB Sciences
- Amgen, Inc.
- AstraZeneca
- Bristol-Myers Squibb Company
- Celgene Corporation
- Daiichi Sankyo Company, Limited
- F. Hoffman-La Roche Ltd.
- Merck & Co., Inc.
- Novartis AG
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Thérapie
- chimiothérapie
- immunothérapie
- thérapie ciblée
- radiothérapie
By Médicaments
- Opdivo
- Yervoy
- Mekinist+Tafinlar
- Keytruda
- Cotellic
- Zelboraf
- Imlygic
- Médicaments génériques
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For